English  |  正體中文  |  简体中文  |  2822948  
???header.visitor??? :  30098589    ???header.onlineuser??? :  961
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"shih j y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 396-420 of 1137  (46 Page(s) Totally)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-03-12T02:29:06Z Tracheal botryomycosis in a patient with tracheopathia osteochondroplastica Shih J.-Y.;Hsueh P.-R.;Chang Y.-L.;Li-Na Lee;Chen Y.-C.;Chen M.-F.;Luh K.-T.; Shih J.-Y.; Hsueh P.-R.; Chang Y.-L.; LI-NA LEE; Chen Y.-C.; Chen M.-F.; Luh K.-T.
臺大學術典藏 2021-03-12T02:29:00Z Tuberculous myositis: A rare but existing clinical entity Wang J.Y.;Li-Na Lee;Hsueh P.R.;Shih J.Y.;Chang Y.L.;Yang P.C.;Luh K.T.; Wang J.Y.; LI-NA LEE; Hsueh P.R.; Shih J.Y.; Chang Y.L.; Yang P.C.; Luh K.T.
臺大學術典藏 2021-03-12T02:28:41Z Coinfection with Mycobacterium tuberculosis and pandemic H1N1 influenza A virus in a patient with lung cancer Tan C.-K.;Kao C.-L.;Shih J.-Y.;Li-Na Lee;Hung C.-C.;Lai C.-C.;Huang Y.-T.;Hsueh P.-R.; Tan C.-K.; Kao C.-L.; Shih J.-Y.; LI-NA LEE; Hung C.-C.; Lai C.-C.; Huang Y.-T.; Hsueh P.-R.
臺大學術典藏 2021-03-12T00:50:59Z Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy Tsai T.-H.;Yang C.-Y.;Ho C.-C.;Liao W.-Y.;I-Shiow Jan;Chen K.-Y.;Wang J.-Y.;Ruan S.-Y.;Yu C.-J.;Yang J.C.H.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; Yang C.-Y.; Ho C.-C.; Liao W.-Y.; I-SHIOW JAN; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2021-03-12T00:50:59Z Survival of lung adenocarcinoma patients with malignant pleural effusion Wu S.-G.;Yu C.-J.;Tsai M.-F.;Liao W.-Y.;Yang C.-H.;I-Shiow Jan;Yang P.-C.;Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; I-SHIOW JAN; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2021-03-12T00:50:57Z BMVC test, an improved fluorescence assay for detection of malignant pleural effusions Lin I.-T.; Tsai Y.-L.; Kang C.-C.; Huang W.-C.; Wang C.-L.; Lin M.-Y.; Lou P.-J.; Shih J.-Y.; Wang H.-C.; Wu H.-D.; Tsai T.-H.; I-SHIOW JAN; Chang T.-C.
臺大學術典藏 2021-03-11T12:03:49Z The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer Yu K.-L.;Tsai T.-H.;Ho C.-C.;Liao W.-Y.;Ching-Kai Lin;Hsu C.-L.;Shih J.-Y.; Yu K.-L.; Tsai T.-H.; Ho C.-C.; Liao W.-Y.; CHING-KAI LIN; Hsu C.-L.; Shih J.-Y.
臺大學術典藏 2021-03-11T08:34:21Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih
臺大學術典藏 2021-03-11T08:34:19Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T08:34:18Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏 2021-03-11T08:34:15Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T08:34:15Z Effect of β-Blocker in Treatment-Naive Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Shih J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Lee C.-H.; JEN-CHANG KO; LIH-YU CHANG; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T08:29:35Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T08:29:34Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T08:29:32Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Liang S.-K.; JEN-CHANG KO; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2021-03-11T08:29:30Z Effect of β-Blocker in Treatment-Na?ve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs Chang C.-H.; Lee C.-H.; JEN-CHANG KO; Chang L.-Y.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T08:29:29Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T07:58:31Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T07:58:28Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T07:58:27Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Liang S.-K.; JEN-CHANG KO; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2021-03-11T07:58:25Z Effect of β-Blocker in Treatment-Na?ve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs Chang C.-H.; Lee C.-H.; JEN-CHANG KO; Chang L.-Y.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T07:58:24Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-08T06:51:51Z Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression Lin C.-C.; Huang Y.-K.; Cho C.-F.; Lin Y.-S.; Lo C.-C.; Kuo T.-T.; Tseng G.-C.; Cheng W.-C.; Chang W.-C.; Hsiao T.-H.; Liang-Chuan Lai; Shih J.-Y.; Liu Y.-H.; Clifford Chao K.S.; Hsu J.L.; Lee P.-C.; Sun X.; Hung M.-C.; Sher Y.-P.
臺大學術典藏 2021-02-23T08:26:39Z Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response Gow C.-H.;Chien C.-R.;Chang Y.-L.;Chiu Y.-H.;Sung-Hsin Kuo;Shih J.-Y.;Chang Y.-C.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Gow C.-H.; Chien C.-R.; Chang Y.-L.; Chiu Y.-H.; SUNG-HSIN KUO; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2021-02-23T08:26:37Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Hsu C.; SUNG-HSIN KUO; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.

Showing items 396-420 of 1137  (46 Page(s) Totally)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
View [10|25|50] records per page